NYSE: EBS · Drug Manufacturers - Specialty & Generic
Over the past week, Emergent Biosolutions (EBS) pulled in 11 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 55% bullish but is deeply split: Reddit runs 100% bullish while News sits at just 33%. Wall Street is more constructive, with 2 of 2 analysts rating EBS a buy.
There is little buzz around EBS this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 33% to Reddit at 100%. No other tracker puts the two side by side.
Across 2 analysts the consensus is a Strong Buy: 2 buy calls against 0 sell, with an average 12-month price target of $11.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 45 points above the crowd average of 55%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 33%, a 67-point spread that single-source trackers miss.
Over the 30-day window, Emergent Biosolutions (EBS) buzz held subdued around 24.9 while the price drifted down 39.8% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.2M shares. Updated Aug 15, 2026. Over the last 7 trading days, EBS lost 13.6%. Buzz activity in the recent week averaged 23.8 and was relatively stable, swinging between 14.6 and 31.5. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 7 of the 11 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for EBS and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live EBS sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (2 / 0 / 0) |
| Crowd bullish (7d) | 55% |
| Avg price target | $11.00 |
| Most bullish source | Reddit, 100% |
| Most bearish source | News, 33% |
| Sentiment spread | 67 pts |
| Mentions (7d) | 11 |
| Market cap | $235.3M |
| P/E · Forward P/E | n/a · 2.1 |
| EPS · Beta | -$3.41 · 2.4 |
| Revenue (TTM) | $770.2M · -23% margin |
| Industry | Drug Manufacturers - Specialty & Generic |
Based on aggregated sentiment from Reddit, X and News sources, Emergent Biosolutions (EBS) currently carries an Adanos hold signal with 59/100 conviction. The current cross-source average reads 55% bullish across 3 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Emergent Biosolutions (EBS) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 2 tracked subreddits. The 7-day tone is 100% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bullish on Emergent Biosolutions (EBS), averaging 55% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 100% bullish and News at 33%, a 67-point spread. On the professional side, 2 of 2 analysts rate EBS a buy.
Of the 2 analysts covering Emergent Biosolutions (EBS), 2 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $11.00. That puts the street ahead of the crowd, which averages 55% bullish.
Emergent Biosolutions (EBS)'s cross-source average is bullish at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 100% bullish, News reads 33% bullish and x coverage is the most negative at 33% bullish. The combined signal points to broad mixed pressure with 59/100 conviction.
The cross-source average is bullish for Emergent Biosolutions (EBS) at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is x at 33% bullish. 3-day activity momentum is falling across X. The hold signal carries 59/100 conviction.
News is the dominant discussion channel with 6 mentions (55% of total volume). X contributes 3 mentions and Reddit contributes 2 mentions. The cross-source average is bullish at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. EBS's hold signal at 59/100 conviction reflects a bullish cross-source average at 55% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The EBS sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key